Senti Biosciences is trading at $0.34 (+9.83%) in pre-market, with no clear company-specific catalyst emerging overnight.

  • Recent financing, merger, and convertible-note disclosures are dated earlier in September, not September 17, 2026.
  • S&P 500 futures are up 0.79% and Nasdaq futures 1.02%; approximately 362,014 pre-market shares have traded.